The polymorphism rs3024505 (C/T) downstream of the IL10 gene is associated with crohn’s disease in serbian patients with inflammatory bowel disease

Tohoku Journal of Experimental Medicine

Volumn 240, Issue 1, 2016, Pages 15-24

  Mijac, Dragana ^a   Petrovic, Irena Vukovic ^a   Djuranovic, Srdjan ^a   Perovic, Vladimir ^a   Bojic, Daniela ^b   Culafic, Djordje ^a   Popovic, Dragan ^a   Krstic, Miodrag ^a   Jankovic, Goran ^a   Djoric, Milica ^a   Pravica, Vera ^a   Markovic, Milos ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

Author keywords

Crohn s disease; Interleukin 10; Rs3024505; Single nucleotide polymorphisms; Ulcerative colitis

Indexed keywords

INTERLEUKIN 10; IL10 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANEMIA; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IL10 GENE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SERBIAN (CITIZEN); SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; ADOLESCENT; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SERBIA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SERBIA; YOUNG ADULT;

EID: 84983670615     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.240.15     Document Type: Article

References (58)

1. Abraham, C. & Cho, J.H. (2009) Inflammatory bowel disease. N. Engl. J. Med., 361, 2066-2078
2. Ahirwar, D.K., Kesarwani, P., Singh, R., Ghoshal, U.C. & Mittal, R.D. (2012) Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. J. Gastrointest. Cancer, 43, 196-204
3. Amre, D.K., Mack, D.R., Morgan, K., Israel, D., Lambrette, P., Costea, I., Krupoves, A., Fegury, H., Dong, J., Grimard, G., Deslandres, C., Levy, E. & Seidman, E.G. (2009) Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn’s disease. Aliment. Pharmacol. Ther., 29, 1025-1031
4. Andersen, V., Ernst, A., Christensen, J., Ostergaard, M., Jacobsen, B.A., Tjonneland, A., Krarup, H.B. & Vogel, U. (2010) The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish casecontrol study. BMC Med. Genet., 11, 82
5. Anderson, C.A., Boucher, G., Lees, C.W., Franke, A., D’Amato, M., Taylor, K.D., Lee, J.C., Goyette, P., Imielinski, M., Latiano, A., Lagace, C., Scott, R., Amininejad, L., Bumpstead, S., Baidoo, L., et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet., 43, 246-252
6. Balding, J., Livingstone, W.J., Conroy, J., Mynett-Johnson, L., Weir, D.G., Mahmud, N. & Smith, O.P. (2004) Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm., 13, 181-187
7. Bank, S., Skytt Andersen, P., Burisch, J., Pedersen, N., Roug, S., Galsgaard, J., Ydegaard Turino, S., Brodersen, J.B., Rashid, S., Kaiser Rasmussen, B., Avlund, S., Bastholm Olesen, T., Jurgen Hoffmann, H., Kragh Thomsen, M., Ostergaard Thomsen, V., et al. (2014) Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort. PloS One, 9, e98815
8. Barrett, J.C., Hansoul, S., Nicolae, D.L., Cho, J.H., Duerr, R.H., Rioux, J.D., Brant, S.R., Silverberg, M.S., Taylor, K.D., Barmada, M.M., Bitton, A., Dassopoulos, T., Datta, L.W., Green, T., Griffiths, A.M., et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet., 40, 955-962
9. Cantor, M.J., Nickerson, P. & Bernstein, C.N. (2005) The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am. J. Gastroenterol., 100, 1134-1142
10. Castro-Santos, P., Suarez, A., Lopez-Rivas, L., Mozo, L. & Gutierrez, C. (2006) TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am. J. Gastroenterol., 101, 1039-1047
11. Celik, Y., Dagli, U., Kilic, M.Y., Toruner, M., Ozen, S.C., Ozkan, M., Soykan, I., Cetinkaya, H., Ulker, A., Ozden, A. & Bozdayi, A.M. (2006) Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand. J. Gastroenterol., 41, 559-565
12. Dignass, A., Eliakim, R., Magro, F., Maaser, C., Chowers, Y., Geboes, K., Mantzaris, G., Reinisch, W., Colombel, J.F., Vermeire, S., Travis, S., Lindsay, J.O. & Van Assche, G. (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J. Crohns Colitis, 6, 965-990
13. Doecke, J.D., Simms, L.A., Zhao, Z.Z., Huang, N., Hanigan, K., Krishnaprasad, K., Roberts, R.L., Andrews, J.M., Mahy, G., Bampton, P., Lewindon, P., Florin, T., Lawrance, I.C., Gearry, R.B., Montgomery, G.W., et al. (2013) Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn’s disease. Inflamm. Bowel Dis., 19, 240-245
14. Engelhardt, K.R. & Grimbacher, B. (2014) IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr. Top. Microbiol. Immunol., 380, 1-18
15. Excoffier, L. & Lischer, H.E. (2010) Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol. Ecol. Resour., 10, 564-567
16. Fernandez, L., Martinez, A., Mendoza, J.L., Urcelay, E., Fernandez-Arquero, M., Garcia-Paredes, J., Diaz-Rubio, M. & de la Concha, E.G. (2005) Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm. Bowel Dis., 11, 739-743
17. Festen, E.A., Stokkers, P.C., van Diemen, C.C., van Bodegraven, A.A., Boezen, H.M., Crusius, B.J., Hommes, D.W., van der Woude, C.J., Balschun, T., Verspaget, H.W., Schreiber, S., de Jong, D.J., Franke, A., Dijkstra, G., Wijmenga, C., et al. (2010) Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am. J. Gastroenterol., 105, 395-402
18. Fowler, E.V., Eri, R., Hume, G., Johnstone, S., Pandeya, N., Lincoln, D., Templeton, D. & Radford-Smith, G.L. (2005) TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn’s disease. J. Med. Genet., 42, 523-528
19. Franke, A., Balschun, T., Karlsen, T.H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F.S., Albrecht, M., Nothnagel, M., Ellinghaus, D., Sina, C., Onnie, C.M., Weersma, R.K., Stokkers, P.C., Wijmenga, C., et al. (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet., 40, 1319-1323
20. Franke, A., McGovern, D.P., Barrett, J.C., Wang, K., Radford-Smith, G.L., Ahmad, T., Lees, C.W., Balschun, T., Lee, J., Roberts, R., Anderson, C.A., Bis, J.C., Bumpstead, S., Ellinghaus, D., Festen, E.M., et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat. Genet., 42, 1118-1125
21. Garza-Gonzalez, E., Perez-Perez, G.I., Mendoza-Ibarra, S.I., Flores-Gutierrez, J.P. & Bosques-Padilla, F.J. (2010) Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population. Int. J. Immunogenet., 37, 355-359
22. Groux, H. & Cottrez, F. (2003) The complex role of interleukin-10 in autoimmunity. J. Autoimmun., 20, 281-285
23. Harvey, R.F. & Bradshaw, J.M. (1980) A simple index of Crohn’sdisease activity. Lancet, 1, 514
24. Hess, J., Angel, P. & Schorpp-Kistner, M. (2004) AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci., 117, 5965-5973
25. Hong, J., Leung, E., Fraser, A.G., Merriman, T.R., Vishnu, P. & Krissansen, G.W. (2008) IL4, IL10, IL16, and TNF polymorphisms in New Zealand Caucasian Crohn’s disease patients. Int. J. Colorectal Dis., 23, 335-337
26. Imielinski, M., Baldassano, R.N., Griffiths, A., Russell, R.K., Annese, V., Dubinsky, M., Kugathasan, S., Bradfield, J.P., Walters, T.D., Sleiman, P., Kim, C.E., Muise, A., Wang, K., Glessner, J.T., Saeed, S., et al. (2009) Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat. Genet., 41, 1335-1340
27. Juyal, G., Prasad, P., Senapati, S., Midha, V., Sood, A., Amre, D., Juyal, R.C. & Bk, T. (2011) An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PloS One, 6, e16565
28. Kim, T.H., Kim, B.G., Shin, H.D., Kim, J.W., Kim, C.G., Kim, J.S., Jung, H.C. & Song, I.S. (2003) Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease. Korean J. Gastroenterol., 42, 377-386
29. Klausz, G., Molnar, T., Nagy, F., Gyulai, Z., Boda, K., Lonovics, J. & Mandi, Y. (2005) Polymorphism of the heat-shock protein gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is associated with the outcome of Crohn’s disease. Scand. J. Gastroenterol., 40, 1197-1204
30. Klein, W., Tromm, A., Griga, T., Fricke, H., Folwaczny, C., Hocke, M., Eitner, K., Marx, M., Runte, M. & Epplen, J.T. (2000) The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis, 21, 3578-3582
31. Kole, A. & Maloy, K.J. (2014) Control of intestinal inflammation by interleukin-10. Curr. Top. Microbiol. Immunol., 380, 19-38
32. Koss, K., Satsangi, J., Fanning, G.C., Welsh, K.I. & Jewell, D.P. (2000) Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun., 1, 185-190
33. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263-274
34. Le, T., Leung, L., Carroll, W.L. & Schibler, K.R. (1997) Regulation of interleukin-10 gene expression: possible mechanisms accounting for its upregulation and for maturational differences in its expression by blood mononuclear cells. Blood, 89, 4112-4119
35. Lopez-Hernandez, R., Valdes, M., Campillo, J.A., Martinez-Garcia, P., Salama, H., Bolarin, J.M., Martinez, H., Moya-Quiles, M.R., Minguela, A., Sanchez-Torres, A., Botella, C., Salgado, G., Miras, M., Carballo, F. & Muro, M. (2015) Proand anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease. Int. J. Immunogenet., 42, 38-45
36. Lv, H., Jiang, Y., Li, J., Zhang, M., Shang, Z., Zheng, J., Wu, X., Liu, P., Zhang, R. & Yu, H. (2014) Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease. Mol. Biol. Rep., 41, 1299-1310
37. M’Koma, A.E. (2013) Inflammatory bowel disease: an expanding global health problem. Clin. Med. Insights Gastroenterol., 6, 33-47
38. Ouma, C., Davenport, G.C., Were, T., Otieno, M.F., Hittner, J.B., Vulule, J.M., Martinson, J., Ong’echa, J.M., Ferrell, R.E. & Perkins, D.J. (2008) Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum. Genet., 124, 515-524
39. Ouyang, W., Rutz, S., Crellin, N.K., Valdez, P.A. & Hymowitz, S.G. (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol., 29, 71-109
40. Perovic, D., Perovic, V., Pravica, V., Bonaci-Nikolic, B., Mijanovic, R. & Bunjevacki, V. (2016) Evaluation of cytokine genetic polymorphisms in adult patients with common variable immunodeficiency: a single-center study. Immunol. Lett., 176, 97-104
41. Pezerovic, D., Klarin, I., Zulj, M., Majnaric, L., Khaznadar, E. & Vcev, A. (2014) Incidence and prevalence of inflammatory bowel disease in Vukovarsko-Srijemska County, Croatia, 1991-2000 and 2001-2010: a population-based study. Coll. Antropol., 38, 115-123
42. Sanchez, R., Levy, E., Costea, F. & Sinnett, D. (2009) IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn’s disease location. World J. Gastroenterol., 15, 3776-3782
43. Satsangi, J., Silverberg, M.S., Vermeire, S. & Colombel, J.F. (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut, 55, 749-753
44. Shin, H.D., Winkler, C., Stephens, J.C., Bream, J., Young, H., Goedert, J.J., O’Brien, T.R., Vlahov, D., Buchbinder, S., Giorgi, J., Rinaldo, C., Donfield, S., Willoughby, A., O’Brien, S.J. & Smith, M.W. (2000) Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl. Acad. Sci. USA, 97, 14467-14472
45. Sincic, B.M., Vucelic, B., Persic, M., Brncic, N., Erzen, D.J., Radakovic, B., Micovic, V. & Stimac, D. (2006) Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: a prospective population-based study. Scand. J. Gastroenterol., 41, 437-444
46. Suarez, A., Castro, P., Alonso, R., Mozo, L. & Gutierrez, C. (2003) Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation, 75, 711-717
47. Tagore, A., Gonsalkorale, W.M., Pravica, V., Hajeer, A.H., McMahon, R., Whorwell, P.J., Sinnott, P.J. & Hutchinson, I.V. (1999) Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens, 54, 386-390
48. Tanaka, M., Masuda, T., Yao, T., Saito, H., Kusumi, T., Nagura, H. & Kudo, H. (2001) Observer variation of diagnoses based on simple biopsy criteria differentiating among Crohn’s disease, ulcerative colitis, and other forms of colitis. J. Gastroenterol. Hepatol., 16, 1368-1372
49. Tedde, A., Laura Putignano, A., Bagnoli, S., Congregati, C., Milla, M., Sorbi, S., Genuardi, M. & Papi, L. (2008) Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand. J. Gastroenterol., 43, 712-718
50. Tilg, H., Ulmer, H., Kaser, A. & Weiss, G. (2002a) Role of IL-10 for induction of anemia during inflammation. J. Immunol., 169, 2204-2209
51. Tilg, H., van Montfrans, C., van den Ende, A., Kaser, A., van Deventer, S.J., Schreiber, S., Gregor, M., Ludwiczek, O., Rutgeerts, P., Gasche, C., Koningsberger, J.C., Abreu, L., Kuhn, I., Cohard, M., LeBeaut, A., et al. (2002b) Treatment of Crohn’s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut, 50, 191-195
52. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnott, P.J. & Hutchinson, I.V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet., 24, 1-8
53. Van Assche, G., Dignass, A., Panes, J., Beaugerie, L., Karagiannis, J., Allez, M., Ochsenkuhn, T., Orchard, T., Rogler, G., Louis, E., Kupcinskas, L., Mantzaris, G., Travis, S. & Stange, E. (2010) The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J. Crohns Colitis, 4, 7-27
54. Vegh, Z., Burisch, J., Pedersen, N., Kaimakliotis, I., Duricova, D., Bortlik, M., Avnstrom, S., Vinding, K.K., Olsen, J., Nielsen, K.R., Katsanos, K.H., Tsianos, E.V., Lakatos, L., Schwartz, D., Odes, S., et al. (2014) Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J. Crohns Colitis, 8, 1506-1515
55. Wang, A.H., Lam, W.J., Han, D.Y., Ding, Y., Hu, R., Fraser, A.G., Ferguson, L.R. & Morgan, A.R. (2011) The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn’s disease susceptibility in a New Zealand population. Hum. Immunol., 72, 431-435
56. Westendorp, R.G., Langermans, J.A., Huizinga, T.W., Elouali, A.H., Verweij, C.L., Boomsma, D.I. & Vandenbroucke, J.P. (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet, 349, 170-173
57. Zhu, H., Lei, X., Liu, Q. & Wang, Y. (2013) Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects. Cytokine, 61, 146-153
58. Zou, L., Wang, L., Gong, X., Zhao, H., Jiang, A. & Zheng, S. (2014) The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis. Autoimmunity, 47, 27-39.